Drug Therapy in Attention-Deficit Hyperactivity Disorder
@article{Kessler1996DrugTI,
title={Drug Therapy in Attention-Deficit Hyperactivity Disorder},
author={S Kessler},
journal={Southern Medical Journal},
year={1996},
volume={89},
pages={33-38}
}Of 292 patients (210 males and 82 females) receiving medication for attentiondeficit hyperactivity disorder (ADHD), 272 (93%) responded well to sustained-release dextroamphetamine (D-Amp) and 21 patients (7%) to sustained-release methylphenidate (MPD). The dose of D-Amp ranged from 0.2 to 3.6 mg/kg/day and the dose of MPD from 1.4 to 7.7 mg/kg/day, without side effects requiring cessation of therapy. This suggests that the clinical improvement rate can be increased to nearly 100% in appropriate…
Topics from this paper
10 Citations
Attention-deficit hyperactivity disorder. Pharmacotherapy and beyond.
- MedicinePostgraduate medicine
- 1997
As more studies evaluate nonpharmacologic approaches such as behavior therapy, parent education, and neurofeedback and more physicians implement multimodal treatment, outcomes for patients with ADHD are expected to be even more positive.
How High a Dose of Stimulant Medication in Adult Attention Deficit Hyperactivity Disorder?
- Psychology, MedicineThe Australian and New Zealand journal of psychiatry
- 2000
The clinical and experimental data justify the use of chronic low-dose stimulant treatment of ADHD in adults, with the recommended upper limit of dose being 1 mg/kg for methylphenidate and 0.5 mg/ kg for dexamphetamine.
Lifetime evolution of ADHD treatment
- MedicineJournal of Neural Transmission
- 2021
A naturalistic review to review and comment on the available literature of ADHD treatment across the lifespan finds stimulants are endowed of a prompt efficacy and safety, whilst non-stimulants are useful when a substance abuse history is detected.
ADHD With Comorbid Bipolar Disorders: A Systematic Review of Neurobiological, Clinical And Pharmacological Aspects Across The Lifespan.
- MedicineCurrent medicinal chemistry
- 2019
A systematic review of the scientific literature on the neurobiological, clinical features and current pharmacological management of ADHD comorbid with BDs across the entire lifespan, with a major focus on the adulthood.
AUTOPERCEPÇÃO DE CRIANÇAS DESATENTAS NO AMBIENTE ESCOLAR SELF-PERCEPTION OF INATTENTIVE CHILDREN IN THE SCHOOL ENVIRONMENT
- Psychology
- 2002
This study is part of a larger study on identification of inattentive children and their behaviors in the school environment, its object having been to identify inattentive children and verify how…
Autopercepção de crianças desatentas no ambiente escolar
- Psychology
- 2002
This study is part of a larger study on identification of inattentive children and their behaviors in the school environment, its object having been to identify inattentive children and verify how…
Instabilité psychomotrice, hyperactivité chez l'enfant: perspectives cliniques et thérapeutiques
- Philosophy
- 1996
L'instabilite psychomotrice chez l'enfant a ete decrite des la fin du XIXe siecle et suscite encore actuellement de nombreuses controverses, notamment entre cliniciens nord-americains et francais. Si…
Comportamentos Disruptivos e Sucesso Académico: A Importância de Variáveis Psicológicas e de Ambiente
- Psychology
- 2010
A presente investigacao teve como objectivo estudar o impacto do autoconceito e do ambiente da sala de aula nos comportamentos disruptivos, como tambem a influencia destes comportamentos nas notas…
School Experiences of Non-Medicated Children Diagnosed with Attention Deficit Hyperactivity Disorder
- Medicine
- 2019
Attention-deficit/hyperactivity disorder: focus on pharmacologic management.
- MedicineJournal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners
- 1997